BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 18825382)

  • 1. Linear quadratic and tumour control probability modelling in external beam radiotherapy.
    O'Rourke SF; McAneney H; Hillen T
    J Math Biol; 2009 Apr; 58(4-5):799-817. PubMed ID: 18825382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigating the effect of cell repopulation on the tumor response to fractionated external radiotherapy.
    Stavreva NA; Stavrev PV; Warkentin B; Fallone BG
    Med Phys; 2003 May; 30(5):735-42. PubMed ID: 12772979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are more complicated tumour control probability models better?
    Gong J; Dos Santos MM; Finlay C; Hillen T
    Math Med Biol; 2013 Mar; 30(1):1-19. PubMed ID: 22006625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A stochastic model for tumour control probability that accounts for repair from sublethal damage.
    Ponce Bobadilla AV; Maini PK; Byrne H
    Math Med Biol; 2018 Jun; 35(2):181-202. PubMed ID: 28339783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In the linear quadratic model, the Poisson approximation and the Zaider-Minerbo formula agree on the ranking of tumor control probabilities, up to a critical cell birth rate.
    Ballhausen H; Belka C
    Int J Radiat Biol; 2017 Mar; 93(3):279-285. PubMed ID: 27658488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dosimetry in nuclear medicine therapy: radiobiology application and results.
    Strigari L; Benassi M; Chiesa C; Cremonesi M; Bodei L; D'Andrea M
    Q J Nucl Med Mol Imaging; 2011 Apr; 55(2):205-21. PubMed ID: 21386791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological optimization of heterogeneous dose distributions in systemic radiotherapy.
    Strigari L; D'Andrea M; Maini CL; Sciuto R; Benassi M
    Med Phys; 2006 Jun; 33(6):1857-66. PubMed ID: 16872093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell-cycle times and the tumour control probability.
    Maler A; Lutscher F
    Math Med Biol; 2010 Dec; 27(4):313-42. PubMed ID: 19966342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The alfa and beta of tumours: a review of parameters of the linear-quadratic model, derived from clinical radiotherapy studies.
    van Leeuwen CM; Oei AL; Crezee J; Bel A; Franken NAP; Stalpers LJA; Kok HP
    Radiat Oncol; 2018 May; 13(1):96. PubMed ID: 29769103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal number and sizes of the doses in fractionated radiotherapy according to the LQ model.
    Bruni C; Conte F; Papa F; Sinisgalli C
    Math Med Biol; 2019 Mar; 36(1):1-53. PubMed ID: 29346681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RADBIOMOD: A simple program for utilising biological modelling in radiotherapy plan evaluation.
    Chang JH; Gehrke C; Prabhakar R; Gill S; Wada M; Lim Joon D; Khoo V
    Phys Med; 2016 Jan; 32(1):248-54. PubMed ID: 26549777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Should single or distributed parameters be used to explain the steepness of tumour control probability curves?
    Daşu A; Toma-Daşu I; Fowler JF
    Phys Med Biol; 2003 Feb; 48(3):387-97. PubMed ID: 12608614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of tumor repopulation on radiotherapy planning.
    Wang JZ; Li XA
    Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):220-7. PubMed ID: 15629615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of external beam radiotherapy and brachytherapy for localized prostate cancer using equivalent uniform dose.
    Wang JZ; Li XA
    Med Phys; 2003 Jan; 30(1):34-40. PubMed ID: 12557976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of adaptive radiotherapy of bladder cancer by image-based tumour control probability modelling.
    Wright P; Muren LP; Høyer M; Malinen E
    Acta Oncol; 2010 Oct; 49(7):1045-51. PubMed ID: 20831494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimization of tumour control probability for heterogeneous tumours in fractionated radiotherapy treatment protocols.
    Levin-Plotnik D; Hamilton RJ
    Phys Med Biol; 2004 Feb; 49(3):407-24. PubMed ID: 15012010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of patient variation on standard- and hypo-fractionated radiotherapy of prostate cancer.
    Xiong W; Li J; Ma CM
    Phys Med Biol; 2005 Apr; 50(7):1483-92. PubMed ID: 15798338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimization of tumour control probability in hypoxic tumours by radiation dose redistribution: a modelling study.
    Søvik A; Malinen E; Bruland ØS; Bentzen SM; Olsen DR
    Phys Med Biol; 2007 Jan; 52(2):499-513. PubMed ID: 17202629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repopulation of interacting tumor cells during fractionated radiotherapy: stochastic modeling of the tumor control probability.
    Fakir H; Hlatky L; Li H; Sachs R
    Med Phys; 2013 Dec; 40(12):121716. PubMed ID: 24320502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential implications of the bystander effect on TCP and EUD when considering target volume dose heterogeneity.
    Balderson MJ; Kirkby C
    Int J Radiat Biol; 2015 Jan; 91(1):54-61. PubMed ID: 25004946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.